Joyeaux Kit
Product Images NDC 70700-177

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Joyeaux (NDC 70700-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Figure 1)

Figure 1. Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Figure 1)
A forest plot comparing effect estimates of combined oral contraceptive (COC) use versus never use from various studies. It includes odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals plotted along an effect estimate axis ranging from -1.50 to 2.00. Studies include the NICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
Two line graphs depicting plasma concentration over time (hours) for Levonorgestrel and Ethinyl Estradiol. The top graph shows Levonorgestrel concentration peaking early and declining over 96 hours. The bottom graph shows Ethinyl Estradiol concentration peaking early and also declining over 96 hours. Both graphs include error bars.*
FDA Label Image

Instructions For Use (Figure A)

Instructions For Use (Figure A)
The image shows a medication blister pack label for Joyeaux, containing Levonorgestrel and Ethinyl Estradiol and Ferrous Fumarate tablets USP. The pack is organized into four rows representing four weeks, with pills for each day labeled Sunday through Saturday. Week 4 pills are shaded, indicating a different formulation, likely the iron tablets. Arrows indicate the direction to take the pills from left to right each week. Labeler is Xiromed, LLC.*
FDA Label Image

Instructions For Use (Figure B)

Instructions For Use (Figure B)
An instructional diagram illustrating the correct sequence for taking pills in a 28-day oral contraceptive kit. It shows four rows labeled Week 1 to Week 4 with circular pill symbols, where Weeks 1 to 3 have empty circles and Week 4 has shaded circles representing placebo or iron tablets. An arrow guides the direction from left to right for each week, and a hand is shown holding the pill pack from the top right corner.*
FDA Label Image

Joyeaux Carton (Joyeaux Carton)

Joyeaux Carton (Joyeaux Carton)
Joyeaux kit containing Levonorgestrel and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets with strengths of 0.1 mg and 0.02 mg respectively. The label displays a 28-day regimen with 3 blister packs of 28 tablets and is labeled for Rx only. The product is manufactured by Xiromed, LLC and the packaging shows NDC 70700-177-85.*
FDA Label Image

Chance Of Getting Pregnant For Different Methods Of Birth Control (Pregnancy Risk)

Chance Of Getting Pregnant For Different Methods Of Birth Control (Pregnancy Risk)
An illustrated vertical chart comparing pregnancy rates associated with different contraceptive methods. The chart ranges from fewer pregnancies at the top (fewer than 1 pregnancy per 100 women per year) to more pregnancies at the bottom (85 or more per 100 women per year). Methods listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, behavior-based methods (no sex during fertile days), spermicide, withdrawal, and no birth control.*
FDA Label Image

Molecular Structures (Structures)

Molecular Structures (Structures)
Chemical structure diagram showing Levonorgestrel (C21H28O2, MW 312.4) on the left and Ethinyl Estradiol (C20H24O2, MW 296.4) on the right, illustrating the molecular formulas and weights of both active ingredients in the drug Joyeaux.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.